We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
IFF Gains From Focus on Growth Despite Low Food Ingredient Volumes
Read MoreHide Full Article
Key Takeaways
IFF is optimizing its portfolio, exiting Pharma and other non-core assets to focus on flavors and fragrances.
IFF is boosting investment in high-return segments while targeting efficiency gains and acquisition synergies.
IFF faces near-term headwinds from low Food Ingredients volumes, FX risks and divestiture impacts in 2025.
International Flavors & Fragrances Inc. (IFF - Free Report) is focused on gaining share in emerging markets. Its disciplined approach to capital allocation will drive growth in the coming years. The company’s acquisitions and investments also bode well. International Flavors completed the sale of its Pharma segment to focus on its core business, which should drive growth in the coming years.
However, lower volume growth for its Food Ingredients business is expected to affect margins. The company is exposed to currency-translation risks, which impact its top-line growth.
Factors Aiding IFF’s Stock
Demand for Flavors & Fragrances: International Flavors is well-poised to benefit from the demand for a variety of consumer products containing flavors and fragrances going forward. Anticipated growth in emerging markets will likely be a key catalyst. International Flavors is focused on gaining share in emerging markets.
Backed by the company’s global presence, diversified business platform, broad product portfolio, and global and regional customer base, it will be able to capitalize on the expansion in flavors and fragrances markets, and deliver long-term growth. The company’s focus on driving greater efficiencies throughout the business through costs and productivity initiatives, margin improvement and acquisition-related synergies continues to drive profits.
Portfolio Optimization Efforts: To drive growth, the company plans to step up its investment in high-return businesses, such as Flavors, Fragrances, Health, Cultures & Food Enzymes. In May 2025, International Flavors completed the divestiture of its Pharma Solutions business unit to Roquette and its nitrocellulose business to Czechoslovak Group.
At the beginning of the first quarter of 2025, the company separated its Nourish segment into the Taste and Food Ingredients segments as part of a broader strategy to reorganize businesses around end markets.
At the end of the second quarter of 2025, the company announced that it inked an agreement to sell its soy crush, concentrates and lecithin business to Bunge. This move, expected to close by the end of 2025, aligns with International Flavors’ portfolio optimization goals and includes evaluating strategic alternatives for the Food Ingredients segment. These endeavors will enable the company to focus on its core business operations, strengthen its balance sheet and maximize shareholder returns.
Disciplined Capital Allocation Approach: International Flavors continues to maintain a disciplined approach to capital allocation even as it focuses on accelerating growth through organic investments and strategic acquisitions, while returning significant capital to shareholders.
It continues to effectively manage its balance sheet by taking necessary actions to generate strong cash flow and maintain ample liquidity by reducing operational and capital expenses. The completion of Pharma Solutions' divestiture further helped International Flavors deliver a net debt to credit-adjusted EBITDA of below 2.5X.
Near-Term Concerns for International Flavors’
The company's presence in international markets (accounting for 75% of its net sales) has exposed it to currency-translation risks. The company is working to offset tariffs, but uncertainty will likely continue to pose challenges. Moreover, the Food Ingredients business is expected to see lower volume growth in 2025.
The Pharma Solutions divestiture is expected to have a negative impact of five percentage points on top-line growth and a negative impact of six percentage points on adjusted EBITDA growth in 2025. The company anticipates fiscal 2025 sales between $10.6 billion and $10.9 billion. International Flavors’ net sales were $11.48 billion in 2024.
IFF Stock’s Price Performance
In the past year, the company’s shares have lost 17.8% against the industry’s 0.8% growth.
Image Source: Zacks Investment Research
International Flavors’ Zacks Rank & Stocks to Consider
The consensus estimate for Agnico Eagle Mines’ 2025 earnings is pegged at $7.77 per share. The estimate indicates year-over-year growth of 83.6%. It has an average trailing four-quarter earnings surprise of 11.6%. Agnico Eagle Mines’ shares have surged 107.6% in a year.
The Zacks Consensus Estimate for Kinross Gold’s 2025 earnings is pegged at $1.67 per share, suggesting year-over-year growth of 145%. Kinross Gold’s shares jumped 135% last year.
The consensus estimate for Fortuna Mining’s 2025 earnings is pegged at 76 cents per share. The estimate implies year-over-year growth of 65.2%. Fortuna Mining’s shares have surged 145.6% in a year.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
IFF Gains From Focus on Growth Despite Low Food Ingredient Volumes
Key Takeaways
International Flavors & Fragrances Inc. (IFF - Free Report) is focused on gaining share in emerging markets. Its disciplined approach to capital allocation will drive growth in the coming years. The company’s acquisitions and investments also bode well. International Flavors completed the sale of its Pharma segment to focus on its core business, which should drive growth in the coming years.
However, lower volume growth for its Food Ingredients business is expected to affect margins. The company is exposed to currency-translation risks, which impact its top-line growth.
Factors Aiding IFF’s Stock
Demand for Flavors & Fragrances: International Flavors is well-poised to benefit from the demand for a variety of consumer products containing flavors and fragrances going forward. Anticipated growth in emerging markets will likely be a key catalyst. International Flavors is focused on gaining share in emerging markets.
Backed by the company’s global presence, diversified business platform, broad product portfolio, and global and regional customer base, it will be able to capitalize on the expansion in flavors and fragrances markets, and deliver long-term growth. The company’s focus on driving greater efficiencies throughout the business through costs and productivity initiatives, margin improvement and acquisition-related synergies continues to drive profits.
Portfolio Optimization Efforts: To drive growth, the company plans to step up its investment in high-return businesses, such as Flavors, Fragrances, Health, Cultures & Food Enzymes. In May 2025, International Flavors completed the divestiture of its Pharma Solutions business unit to Roquette and its nitrocellulose business to Czechoslovak Group.
At the beginning of the first quarter of 2025, the company separated its Nourish segment into the Taste and Food Ingredients segments as part of a broader strategy to reorganize businesses around end markets.
At the end of the second quarter of 2025, the company announced that it inked an agreement to sell its soy crush, concentrates and lecithin business to Bunge. This move, expected to close by the end of 2025, aligns with International Flavors’ portfolio optimization goals and includes evaluating strategic alternatives for the Food Ingredients segment. These endeavors will enable the company to focus on its core business operations, strengthen its balance sheet and maximize shareholder returns.
Disciplined Capital Allocation Approach: International Flavors continues to maintain a disciplined approach to capital allocation even as it focuses on accelerating growth through organic investments and strategic acquisitions, while returning significant capital to shareholders.
It continues to effectively manage its balance sheet by taking necessary actions to generate strong cash flow and maintain ample liquidity by reducing operational and capital expenses. The completion of Pharma Solutions' divestiture further helped International Flavors deliver a net debt to credit-adjusted EBITDA of below 2.5X.
Near-Term Concerns for International Flavors’
The company's presence in international markets (accounting for 75% of its net sales) has exposed it to currency-translation risks. The company is working to offset tariffs, but uncertainty will likely continue to pose challenges. Moreover, the Food Ingredients business is expected to see lower volume growth in 2025.
The Pharma Solutions divestiture is expected to have a negative impact of five percentage points on top-line growth and a negative impact of six percentage points on adjusted EBITDA growth in 2025. The company anticipates fiscal 2025 sales between $10.6 billion and $10.9 billion. International Flavors’ net sales were $11.48 billion in 2024.
IFF Stock’s Price Performance
In the past year, the company’s shares have lost 17.8% against the industry’s 0.8% growth.
Image Source: Zacks Investment Research
International Flavors’ Zacks Rank & Stocks to Consider
IFF currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks from the basic materials space are Agnico Eagle Mines (AEM - Free Report) , Kinross Gold Corporation (KGC - Free Report) and Fortuna Mining Corp. (FSM - Free Report) . AEM and KGC sport a Zacks Rank #1 (Strong Buy), and FSM has a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
The consensus estimate for Agnico Eagle Mines’ 2025 earnings is pegged at $7.77 per share. The estimate indicates year-over-year growth of 83.6%. It has an average trailing four-quarter earnings surprise of 11.6%. Agnico Eagle Mines’ shares have surged 107.6% in a year.
The Zacks Consensus Estimate for Kinross Gold’s 2025 earnings is pegged at $1.67 per share, suggesting year-over-year growth of 145%. Kinross Gold’s shares jumped 135% last year.
The consensus estimate for Fortuna Mining’s 2025 earnings is pegged at 76 cents per share. The estimate implies year-over-year growth of 65.2%. Fortuna Mining’s shares have surged 145.6% in a year.